207 related articles for article (PubMed ID: 29436251)
1. Improvement of Metabolic Control and Diabetes Management in Insulin-Treated Patients Results in Substantial Cost Savings for the German Health System.
Fritzen K; Gutschek B; Coucke B; Zakrzewska K; Hummel M; Schnell O
J Diabetes Sci Technol; 2018 Sep; 12(5):1002-1006. PubMed ID: 29436251
[TBL] [Abstract][Full Text] [Related]
2. Impact of a reduced error range of SMBG in insulin-treated patients in Germany.
Schnell O; Erbach M
J Diabetes Sci Technol; 2014 May; 8(3):479-82. PubMed ID: 24876609
[TBL] [Abstract][Full Text] [Related]
3. Higher accuracy of self-monitoring of blood glucose in insulin-treated patients in Germany: clinical and economical aspects.
Schnell O; Erbach M; Wintergerst E
J Diabetes Sci Technol; 2013 Jul; 7(4):904-12. PubMed ID: 23911172
[TBL] [Abstract][Full Text] [Related]
4. Integrated sensor-augmented pump therapy systems [the MiniMed® Paradigm™ Veo system and the Vibe™ and G4® PLATINUM CGM (continuous glucose monitoring) system] for managing blood glucose levels in type 1 diabetes: a systematic review and economic evaluation.
Riemsma R; Corro Ramos I; Birnie R; Büyükkaramikli N; Armstrong N; Ryder S; Duffy S; Worthy G; Al M; Severens J; Kleijnen J
Health Technol Assess; 2016 Feb; 20(17):v-xxxi, 1-251. PubMed ID: 26933827
[TBL] [Abstract][Full Text] [Related]
5. Pan-European Economic Analysis to Identify Cost Savings for the Health Care Systems as a Result of Integrating Glucose Monitoring Based Telemedical Approaches Into Diabetes Management.
Fritzen K; Basinska K; Rubio-Almanza M; Nicolucci A; Kennon B; Vergès B; Zakrzewska K; Schnell O
J Diabetes Sci Technol; 2019 Nov; 13(6):1112-1122. PubMed ID: 30917691
[TBL] [Abstract][Full Text] [Related]
6. Budget Impact of Improved Diabetes Management by Utilization of Glucose Meters With a Color-Range Indicator-Comparison of Five European Healthcare Systems.
Fritzen K; Basinska K; Stautner C; Braun KF; Rubio-Almanza M; Nicolucci A; Kennon B; Vergès B; Hosny Y; Schnell O
J Diabetes Sci Technol; 2020 Mar; 14(2):262-270. PubMed ID: 31387385
[TBL] [Abstract][Full Text] [Related]
7. Economic impact of hypoglycemia among insulin-treated patients with diabetes.
Sussman M; Sierra JA; Garg S; Bode B; Friedman M; Gill M; Kaufman F; Vigersky R; Menzin J
J Med Econ; 2016 Nov; 19(11):1099-1106. PubMed ID: 27292016
[TBL] [Abstract][Full Text] [Related]
8. Rational use of blood glucose test strips for self-monitoring in patients with diabetes mellitus: Economic impact in the Portuguese healthcare system.
Risso T; Furtado C
Diabetes Res Clin Pract; 2017 Dec; 134():161-167. PubMed ID: 28951334
[TBL] [Abstract][Full Text] [Related]
9. Reduction in self-monitoring of blood glucose in persons with type 2 diabetes results in cost savings and no change in glycemic control.
Meier JL; Swislocki AL; Lopez JR; Noth RH; Bartlebaugh P; Siegel D
Am J Manag Care; 2002 Jun; 8(6):557-65. PubMed ID: 12068962
[TBL] [Abstract][Full Text] [Related]
10. Cost-effective use of telemedicine and self-monitoring of blood glucose via Diabetes Tele Management System (DTMS) to achieve target glycosylated hemoglobin values without serious symptomatic hypoglycemia in 1,000 subjects with type 2 diabetes mellitus--a retrospective study.
Kesavadev J; Shankar A; Pillai PB; Krishnan G; Jothydev S
Diabetes Technol Ther; 2012 Sep; 14(9):772-6. PubMed ID: 22734662
[TBL] [Abstract][Full Text] [Related]
11. Effects of real-time continuous glucose monitoring in type 1 diabetes: a meta-analysis of randomized controlled trials.
Dicembrini I; Cosentino C; Monami M; Mannucci E; Pala L
Acta Diabetol; 2021 Apr; 58(4):401-410. PubMed ID: 32789691
[TBL] [Abstract][Full Text] [Related]
12. Budget impact of continuous subcutaneous insulin infusion therapy in patients with type 1 diabetes who experience severe recurrent hypoglycemic episodes in Spain.
Giménez M; Elías I; Álvarez M; Quirós C; Conget I
Endocrinol Diabetes Nutr; 2017; 64(7):377-383. PubMed ID: 28745609
[TBL] [Abstract][Full Text] [Related]
13. [Costs of the treatment of hyperglycemia in patients with diabetes mellitus. The impact of age, type of therapy and complications: results of the German CoDiM study].
von Ferber L; Köster I; Hauner H
Med Klin (Munich); 2006 May; 101(5):384-93. PubMed ID: 16685485
[TBL] [Abstract][Full Text] [Related]
14. Self Monitoring of Blood Glucose Among Patients with Type 2 Diabetes Mellitus in Eastern Nigeria: Need for Multi-strategic Interventions.
Ugwu ET; Orjioke CJG; Young EE
Curr Diabetes Rev; 2018; 14(2):175-181. PubMed ID: 27758706
[TBL] [Abstract][Full Text] [Related]
15. Assessment of metabolic control in patients with diabetes treated with insulin using Contour USB and A1cNow+ devices (COMET study).
Vinagre I; Álvarez P; García N; Roura G; Conget I;
Endocrinol Nutr; 2015 Oct; 62(8):384-90. PubMed ID: 26391507
[TBL] [Abstract][Full Text] [Related]
16. Impact and duration effect of telemonitoring on ΗbA1c, BMI and cost in insulin-treated Diabetes Mellitus patients with inadequate glycemic control: A randomized controlled study.
Fountoulakis S; Papanastasiou L; Gryparis A; Markou A; Piaditis G
Hormones (Athens); 2015; 14(4):632-43. PubMed ID: 26188234
[TBL] [Abstract][Full Text] [Related]
17. Use of a Combined Blood-Glucose- and ß-Ketone-Measuring Device Improves Glycemic Control in Insulin-Treated Patients With Diabetes: The Gold Plus Study.
Ziegler R; Eichholz R; Schulz B
J Diabetes Sci Technol; 2015 May; 9(6):1270-4. PubMed ID: 25986628
[TBL] [Abstract][Full Text] [Related]
18. Structured self-monitoring of blood glucose regimens improve glycemic control in poorly controlled Chinese patients on insulin therapy: Results from COMPASS.
Ji L; Su Q; Feng B; Shan Z; Hu R; Xing X; Xue Y; Yang T; Hua Y
J Diabetes; 2017 May; 9(5):495-501. PubMed ID: 27249791
[TBL] [Abstract][Full Text] [Related]
19. Potential cost savings in the United States from a reduction in sensor-detected severe hypoglycemia among users of the InPen smart insulin pen system.
Chien A; Thanasekaran S; Gaetano A; Im G; Wherry K; MacLeod J; Vigersky RA
J Manag Care Spec Pharm; 2023 Mar; 29(3):285-292. PubMed ID: 36692907
[No Abstract] [Full Text] [Related]
20. Economic Value of Improved Accuracy for Self-Monitoring of Blood Glucose Devices for Type 1 and Type 2 Diabetes in England.
McQueen RB; Breton MD; Craig J; Holmes H; Whittington MD; Ott MA; Campbell JD
J Diabetes Sci Technol; 2018 Sep; 12(5):992-1001. PubMed ID: 29681171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
